Wolverine Asset Management »

Carmell Therapeutics Corp - US shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $65 163 0.40

More positions owned by Wolverine Asset Management

Microstrategy Cl A New Call Option (MSTR)
Coinbase Global Com Cl A Put Option (COIN)
Rivian Automotive Com Cl A Put Option (RIVN)
Draftkings Note 3/1 (Principal)
Royal Caribbean Cruises Put Option (RCL)
Sea Note 2.375%12/0 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Nio Spon Ads Put Option (NIO)
Li Auto Note 0.250% 5/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Airbnb Note 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Zto Express Cayman Note 1.500% 9/0 (Principal)

View all positions for Wolverine Asset Management

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Virtu Financial
Tower Research Capital
Morgan Stanley

View all funds holding Carmell Therapeutics Corp - US